ENTITY
Jacobio Pharmaceuticals

Jacobio Pharmaceuticals (1167 HK)

64
Analysis
Health CareChina
Jacobio Pharmaceuticals Co. Ltd. operates as a biotech company. The Company develops and sells cancer innovative drugs, autoimmune drugs, infectious diseases drugs, and other products. Jacobio Pharmaceuticals markets its products throughout China.
more
Refresh
24 Oct 2020 23:47

What HKEX Biotech "Step-Ups" Can Tell Us

This Insight explains the concept of valuation "step-ups" for pre-revenue biotechnology companies listing on the HKEX and how to use this data to...

Share
21 Oct 2020 02:00

Jacobio Pharma: Focus on Novel Targets

An in-depth overview of the proposed listing of Jacobio Pharmaceuticals using a framework that touches on the science, market opportunity,...

Share
14 Oct 2020 09:57

Jacobio (加科思药业) Pre-IPO: Right Team but Long Time to Market

Jacobio is a clinical stage China biotech company with a focus on small molecule oncology drugs. The company was founded by Dr. Wang, co-founder of...

Logo
435 Views
Share
x